Self-pay GLP-1 patients often report faster treatment initiation, fewer administrative barriers, and ability to choose formulations aligned with their preferencesoral versus injectablewithout coverage restrictions
It eliminates the need for biosimilar-specific prescriber-level marketing for products in therapeutic areas where pharmacy-level dispensing is common
Taking care of your skin post-treatment can help reduce risks, speed up recovery, and enhance the effects of the injectable
Until then, the idea that GLP-1 drugs lower cancer risk is a hypothesis worth testing but not a conclusion to act on
Long-term safety is still being studied, though semaglutide has demonstrated cardiovascular benefit in trials, while tirzepatides long-term cardiovascular outcomes are under evaluation
She is working on a study in a non-veteran population that is echoing what Al-Alys group foundthat the drugs can address many kinds of addictions